CME Webcasts

The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Joseph Saseen, PharmD, CLS

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webcast will review several new nonstatin therapies that have been proven to reduce cardiovascular events, when added to statin therapy.

Learning Objectives

  1. Describe guideline and other expert recommendations of for the use of nonstatin therapy in the management of dyslipidemia
  2. Examine results from cardiovascular outcome trials evaluating non-statin therapies
  3. Review the mechanism of action, efficacy and safety of new and novel LDL-cholesterol lowering medications

Disclosures

none

This enduring material activity, The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins October 12, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fighting the Ladykiller (and side effects) with Cholesterol Lowering Therapy

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Margo B. Minissian, PhD, ACNP

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webcast will focus on lowering cardiovascular risk in women through effective cholesterol management and addressing issues like statin myalgias.

Learning Objectives

  1. Provide two examples why management of cholesterol is different in women compared to men.
  2. List 4 classifications of patients who qualify for statin therapy
  3. Describe 2 clinical pearls to improve statin associated muscle symptoms

Disclosures

none

This enduring material activity, Fighting the Ladykiller (and side effects) with Cholesterol Lowering Therapy, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins October 12, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Review of the Cardiometabolic Effects of Low-Carbohydrate and Very-Low-Carbohydrate (Including Ketogenic) Diets

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webcast will review the NLA Scientific Statement on the “Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force.”

Learning Objectives

  1. Describe the various carbohydrate-restricted dietary patterns.
  2. Review evidence regarding the efficacy of low-carbohydrate diets for weight loss and weight loss management.
  3. Review evidence regarding the effects of low-carbohydrate diets on additional cardiometabolic risk factors, including lipids/lipoproteins, glycemic control, and blood pressure.
  4. Discuss the key recommendations of the National Lipid Association Scientific Statement.
  5. Utilize the key recommendations in clinical practice when counseling patients on the use of low-carbohydrate and very-low-carbohydrate dietary patterns.

Disclosures

none

This enduring material activity, Review of the Cardiometabolic Effects of Low-Carbohydrate and Very-Low-Carbohydrate (Including Ketogenic) Diets, has been reviewed and is acceptable for up to 1.0  prescribed credits by the American Academy of Family Physicians. Term of approval begins July 1, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Should We Measure Lipoprotein(a) and What Should We Do With the Results?

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Samia Mora, MD, MHS

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webcast will review how Lp(a), a genetically derived LDL-like-particle, can increase cardiovascular risk

Learning Objectives

  1. To discuss prevalence, screening, and measurement of lipoprotein(a)
  2. To summarize the relationship of lipoprotein(a) with cardiometabolic risk
  3. To discuss treatment strategies for high lipoprotein(a)

Disclosures

Institutional research grant to the Brigham and Women’s Hospital from Atherotech Diagnostics (2018)

Quest Diagnostics measured Lp(a) in the JUPITER trial

This enduring material activity, Should We Measure Lipoprotein(a) and What Should We Do With the Results?, has been reviewed and is acceptable for up to 1.0  prescribed credits by the American Academy of Family Physicians. Term of approval begins July 1, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Racial/Ethnic Disparities in Cardiovascular Outcomes

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASPC

Time of Talk

30 minutes

CME Accreditation

30 min webcast = 0.50 credits
15 min exam = 0.25 credits
Total = 0.75 credits

Description

This webcast will review the ethnic disparities in cardiovascular outcomes.

Learning Objectives

  1. Describe CVD disparities in risk factor prevalence and outcomes in the United States
  2. Highlight genomic variation and social determinants on CVD
  3. Discuss strategies to eliminate disparities among racial/ethnic minorities

Disclosures
Consultant– Amgen, Sanofi, Boehringer Ingelheim, Novartis, Quantum Genomics

This enduring material activity, Racial/Ethnic Disparities in Cardiovascular Outcomes, has been reviewed and is acceptable for up to 0.75  prescribed credits by the American Academy of Family Physicians. Term of approval begins July 1, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Impact of Periodontal Disease on Metabolic and Cardiovascular Disease

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Dan Sindelar, DMD

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webcast will review the impact of periodontal disease on metabolic and cardiovascular disease.

Learning Objectives

  1. Overview of periodontal disease and oral inflammation
  2. The underlying factors of Periodontal disease that affect cardiovascular risk through systemic inflammation
  3. Overview of current ways to reduce your patient’s cardiovascular risk with a team approach to disease management.

Disclosures
N/A

This enduring material activity, The Impact of Periodontal Disease on Metabolic and Cardiovascular Disease, has been reviewed and is acceptable for up to 1.0  prescribed credits by the American Academy of Family Physicians. Term of approval begins March 30, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Role of Adverse Pregnancy Outcomes in Heart Disease Prevention

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Margo Minissian, PhD, ACNP, FNLA, FAHA

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min exam = 0.25 credits
Total = 1.0 credits

Description

This webinar will review adverse pregnancy outcomes women can encounter and how these can influence cardiovascular risk.

Learning Objectives

  1. Explain why adverse pregnancy outcomes (APOs) are important for heart disease prevention.
  2. Describe the types of adverse pregnancy outcomes that predispose women to increased cardiovascular risk
  3. Discuss heat-healthy lifestyle interventions for women with a history of an adverse pregnancy outcome.

Disclosures
Grant Funding (>$10,000): National Institute for Nursing Research, Beta Chi Chapter, Cedars-Sinai Precision Health Institute, National Institute of Heath Foundation/Ogilvy, National Institute of Nursing Research, Preventive Cardiovascular Nurses Association/American Nurses Foundation

Honorarium ($5,000): NACCME (LLC Co-Chair for CME and consultant), Amgen (Consultant, Medical Advisory Board), Vox Media, Medtelligence

This enduring material activity, The Role of Adverse Pregnancy Outcomes in Heart Disease Prevention, has been reviewed and is acceptable for up to 1.0  prescribed credits by the American Academy of Family Physicians. Term of approval begins March 30, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sleep Health: Healthy Sleep, Healthy Heart

Posted on by

Sleep Health: Healthy Sleep, Healthy Heart

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

 

Param Dedhia, MD

Director of Sleep Medicine

Physician, Internal Medicine and Integrative Medicine

Estimated Time of Talk

30 minutes

CME Accreditation

30 min webcast = 0.50 credits

15 min Q&A = 0.25 credits

Total = 0.75 credits

Description

This webcast will review the impact sleep has on health and how it can influence cardiovascular risk.

Learning Objectives

  1. Review the function sleep plays on various physiological functions
  2. Discuss sleep stages and cycles and how their disruption can affect overall health
  3. Understand key disrupters that can commonly interfere with sleep quality

Disclosures

None

This enduring material activity, Sleep Health: Healthy Sleep, Healthy Heart, has been reviewed and is acceptable for up to 0.75  prescribed credits by the American Academy of Family Physicians. Term of approval begins June 28, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Identifying Subclinical Cardiovascular Disease

Posted on by

Identifying Subclinical Cardiovascular Disease

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

 

Speaker Name/Credentials

Gina Pritchard, MSN, RN, CNS, ACNP

The PREVENT! Clinic, Plano, TX – Owner/Nurse Practitioner

Estimated Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits

15 min Q&A = 0.25 credits

Total = 1.00 credits

Description

This webinar will cover current imaging methods that diagnose cardiovascular disease and biomarkers for the identification of cardiovascular disease.

Learning Objectives

  1. Understand and compare current imaging methodologies to diagnose cardiovascular disease
  2. Understand methods that identify subclinical cardiovascular disease
  3. Explore methods combining results of subclinical disease with biological testing to diagnose and treat patients to prevent disease progression

Disclosures

Speaker – Bale/Doneen Method, Bale/Doneen Practice, Cleveland HeartLab

This enduring material activity, Identifying Subclinical Cardiovascular Disease, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins June 28, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Coronary Calcium Scanning: Role in Preventive Cardiology

Posted on by

Coronary Calcium Scanning: Role in Preventive Cardiology

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Nathan D. Wong, PhD, MPH, FACC, FAHA

Professor and Director

Heart Disease Prevention Program

Division of Cardiology, University of CA, Irvine

Past President, American Society for Preventive Cardiology (ASPC)

Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits

15 min exam = 0.25 credits

Total = 1.00 credits

Description

This webinar will review the studies supporting the use of coronary calcium scoring and its recommendation in the new 2018 cholesterol management guidelines.

Learning Objectives

  1. Understand the background, pathophysiology of coronary calcium and rationale for coronary calcium screening
  2. Understand the relation of coronary calcium to future cardiovascular disease events and mortality
  3. Understand the benefits of coronary calcium screening
  4. Understand the current guidelines for coronary calcium screening and its role in choosing which patients are most suitable for treatment according to the 2018 cholesterol management guidelines

Disclosures

Research support- University of California, Irvine, Amgen, Amarin, Boehringer Ingelheim, and Novo Nordisk
Advisory board- Novartis, Amarin
Speaker- Amarin and Sanofi
Consulting- Astra-Zeneca

This enduring material activity, Coronary Calcium Scanning: Role in Preventive Cardiology, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins June 28, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Aggressive Detection and Reversal of Heart Disease

Posted on by

Aggressive Detection and Reversal of Heart Disease

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Joel Kahn, MD, FACC

Clinical Professor, Wayne State University School of Medicine

Kahn Center for Cardiac Longevity

Estimated Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits

15 min exam = 0.25 credits

Total = 1.00 credits

Description

This webinar will review current methods to detect the early stages of atherosclerosis and nutritional strategies to intervene and potentially reverse disease.

Learning Objectives

  1. Understand early warning signs of atherosclerotic disease
  2. Review lifestyle habits that can prevent disease development and progression
  3. Review specific diets and programs that can reduce cardiovascular risk

Disclosures

Speaker- Quest/Cleveland HeartLab

This enduring material activity, Aggressive Detection and Reversal of Heart Disease, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins June 28, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Oxidative stress: The effect on mitochondria and energy production

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Patrick Hanaway, MD

Director of Research at the Center for Functional Medicine, Cleveland Clinic Faculty of the Institute of Functional Medicine

Estimated Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits

15 min exam = 0.25 credits

Total = 1.0 credits

Description

This webinar will cover how energy production dysregulation due to oxidative stress can result in clinical symptoms, and how diet and lifestyle can be used to minimize this process.

Learning Objective

  1. Review mitochondrial structure, energy production, and metabolism
  2. Discuss pathophysiology of oxidative stress and mitochondrial damage; including dietary factors, ROS, and toxins
  3. Review ways to support mitochondria: diet, nutrients, and lifestyle

Disclosures
None

This enduring material activity, Oxidative stress: The effect on mitochondria and energy production, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins March 30, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Genetic testing in cardiovascular disease

Posted on by

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Atul K. Sachdev, MD

New Horizon Healthcare

Estimated Time of Talk

30 minutes

CME Accreditation

30 min webcast = 0.50 credits
15 min Q&A = 0.25 credits
Total = 0.75 credits

Description

This webinar will review genetic tests that can be used to assess cardiovascular risk and reviews case studies to show their utility in clinical practice.

Learning Objective

  1. To learn background information on genetic testing for cardiovascular risk
  2. How genetic testing can be used to personalize risk stratification
  3. Learn about different modes of risk mitigation based on genetic testing

Disclosures
Cleveland HeartLab/Quest Diagnostics – Speaker

This enduring material activity, Genetic testing in cardiovascular disease, has been reviewed and is acceptable for up to 0.75 prescribed credits by the American Academy of Family Physicians. Term of approval begins March 30, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.